Vitamin C protects carboplatin-exposed oocytes from meiotic failure
/in International Publications, Micronutrients /von 2019-10-28 / Mol. Hum. Reprod. 2019 10;25(10):601-613Blockage of immune checkpoint molecules increases T-cell priming potential of dendritic cell vaccine
/in Checkpoint-Inhibitors, Dendritic Cells, International Publications /von 2019-10-24 / Immunology 2020 01;159(1):75-87Extracellular Vesicles in Cancer Immune Microenvironment and Cancer Immunotherapy
/in International Publications /von 2019-10-23 / Adv Sci (Weinh) 2019 Dec;6(24):1901779Dendritic cells in pancreatic cancer immunotherapy: Vaccines and combination immunotherapies
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2019-10-17 / Pathol. Res. Pract. 2019 Dec;215(12):152691Survival Comparison between Melanoma Patients Treated with Patient-Specific Dendritic Cell Vaccines and Other Immunotherapies Based on Extent of Disease at the Time of Treatment
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2019-10-11 / Biomedicines 2019 Oct;7(4)Immunotherapy Based on Dendritic Cell-Targeted/-Derived Extracellular Vesicles-A Novel Strategy for Enhancement of the Anti-tumor Immune Response
/in Dendritic Cells, International Publications /von 2019-10-11 / Front Pharmacol 2019;10:1152Dendritic Cell Vaccination in Metastatic Melanoma Turns „Non-T Cell Inflamed“ Into „T-Cell Inflamed“ Tumors
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2019-10-09 / Front Immunol 2019;10:2353A chirality-dependent action of vitamin C in suppressing Kirsten rat sarcoma mutant tumor growth by the oxidative combination: Rationale for cancer therapeutics
/in International Publications, Micronutrients /von 2019-10-08 / Int. J. Cancer 2020 05;146(10):2822-2828Curcumin and Cancer
/in Curcuma, International Publications /von 2019-10-05 / Nutrients 2019 Oct;11(10)
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution